Currently, measures to control Staphylococcus aureus infections are challenged by a large and continuing increase in the prevalence of meticillinresistant S. aureus (MRSA) worldwide (Biedenbach et al., 2004; NNISS, 2004) , the spread of highly virulent communityassociated MRSA (Chapman et al., 2005; Sakoulas et al., 2004) , and the emergence of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) strains (Fridkin et al., 2003; Hiramatsu et al., 1997; Robert et al., 2006; Tenover, 2008) . Although VISA and VRSA strains are rare among S. aureus clinical isolates, reports of their emergence have nonetheless alarmed the medical community. There is now also a growing concern about the emergence of S. aureus with increasing MICs to vancomycin. This is due to the fact that analysis of clinical and microbiological data from patients for whom vancomycin therapy failed suggests that the increasing vancomycin MICs for S. aureus, even those well within the current susceptible range (MIC 2 mg ml 21 ) (CLSI, 2006a), might be a significant risk factor for vancomycin treatment failure (Tenover, 2008) .
There is a paucity of data available from the Indian subcontinent surveying the occurrence of S. aureus isolates with reduced susceptibility to vancomycin. In this context, we performed a retrospective study to assess the trends in MIC levels for vancomycin susceptibility of S. aureus strains during a 5 year period in a tertiary hospital of India. Furthermore, a multiplex PCR for simultaneous detection of vanA and vanB genes, and the staphylococcal meticillin-resistance marker mecA, was performed on all the strains evaluated in this study. MICs from 1 to 2 mg ml 21 over the 5 years of our study represent a real clinical problem in the treatment of S. aureus infections with vancomycin.
The possible emergence and dissemination of VRSA strains is a serious health threat, and makes it absolutely necessary to optimize prevention strategies and fast detection methods. The multiplex PCR assay performed in this study is a rapid diagnostic method that can be used to facilitate the detection and identification of S. aureus or MRSA strains carrying vanA or vanB. No strain with high level of vancomycin resistance due to vanA or vanB was observed in this study. However, the emergence of vancomycin-resistant enterococci in our hospital (All India Institute of Medical Sciences) in recent years (Mathur et al., 2003; Dhawan et al., 2009 ) is a cause for concern, as vanA-type resistant genes can be transferred from enterococci to S. aureus thereby further exacerbating the potential for the emergence of VRSA in our hospital setting.
We have previously reported the genetic relatedness analysis of our MRSA strains by PFGE . The MRSA strains with vancomycin MICs of 2 mg ml 21 belonged to PFGE clone III, which is the predominant multidrug resistant clone circulating in our hospital and shows genetic relatedness to the epidemic strain UK EMRSA-1. The propensity of clone III for resistance to different antimicrobials underscores the importance of the implementation of strategies to prevent further clonal spread of MRSA strains. 
